Johnson & Johnson
NYSE: JNJ Healthcare Pharmaceuticals
$263.04
+— (+3.57%)
Johnson & Johnson is the 16th largest stock tracked on DollarScout
by market cap
Market cap: $633.19B · Rank 16 of 60
Key stats
Market cap
$633.19B
Revenue (TTM)
—
Net income (TTM)
—
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Beta (5Y)
—
Shares outstanding
—
52W high
—
52W low
—
Day open
—
Previous close
—
Price chart
Healthcare peers
How JNJ compares to other large companies in the same sector.
| Company | Price | Today | Market cap | P/E |
|---|---|---|---|---|
| LLY Eli Lilly and Company | $1213.91 | +1.86% | $1.08T | — |
| ABBV AbbVie Inc. | $261.07 | +3.99% | $461.26B | — |
| UNH UnitedHealth Group | $425.36 | -0.28% | $386.29B | — |
| MRK Merck & Co. | $129.56 | +3.34% | $319.99B | — |
| PFE Pfizer Inc. | $24.32 | +1.84% | $138.61B | — |
Where to buy JNJ
Open an account with a broker we've reviewed and start trading Johnson & Johnson today.
Robinhood
Commission-free · Best for beginners
Read review →
Webull
Advanced charts · For active traders
Read review →
Fidelity
Low fees · Best for retirement
Read review →
Want to practice first? Try the free Stock Trading Simulator with $100,000 virtual cash.
Disclaimer: The information on this page is provided for informational and educational purposes only and should not be considered financial, investment, or trading advice. DollarScout does not recommend buying or selling any specific security. Stock data may be delayed. Past performance is not indicative of future results. Always do your own research and consult a licensed financial advisor before making investment decisions.